GKC's President and CEO, John Schellhorn, and Senior VP Business Development and Legal Affairs, Michelle Goldsmith, will attend the 2018 J.P. Morgan Healthcare Conference in San Francisco, CA in January.
News & Events
-
GKC attending J.P. Morgan Healthcare Conference 2018 Read more
-
US patent granted for movement recording Read moreGKC has received notification of issuance by the US patent office of a patent covering its key product the Personal KinetiGraph™ (PKG™).
-
Parkinson's KinetiGraph featured in Dutch Parkinson Magazine Read moreThe October edition of the Dutch Parkinson Magazine, published by the Dutch Parkinson's disease Association, highlighted an interview with Anne van der Plas, neurologist at the Alrijne hospital in the Netherlands.
The interview describes how the PKG is used in their hospital and the benefits to both clinicians and patients.
-
GKC names John Schellhorn new President and CEO Read moreGKC announced today that it has appointed John Schellhorn as its new President and CEO. Schellhorn will also be joining the company’s Board of Directors.
Schellhorn joins GKC with a proven track record to spearhead the company's accelerated growth strategy to meet the demand for its lead product, the PKG™ system.
-
A Parkinson’s Doctor Explains How mHealth is Changing Patient Care Read moreDr. Rajesh Pahwa is using an mHealth wearable to gain a better understanding of what his Parkinson's patients go through every day. In essence, he's now 'riding the roller coaster' with them.
Rajesh Pahwa, MD, has long treated his Parkinson's disease patients by sitting them down and asking them how each day has gone in between doctor's visits. Now he's using an mHealth wearable to better understand those days.
-
Global Kinetics Corporation secures first US patent for its digital health system Read moreGlobal Kinetics Corporation (GKC), announced today it has recently received Notice of Allowance for U.S. patent application 12/997540, protecting the company's lead product, the Personal KinetiGraph (PKG) (Parkinson's Kinetigraph outside of the U.S.) system, which the company is marketing in the U.S. The patent application pertains to the objective measurement of bradykinesia. Bradykinesia, or slowness of movement, is one of the most common symptoms, and a defining feature, of Parkinson's disease. The capacity to continuously measure this movement symptom underpins the PKG system. Read more...
